We treated 30 cases of lung cancer at an advanced stage with cisplatin combined with thrombin by introducing a tube into thorex. Our results show CR was 30%, PR was 60% and NR was 10%. The total improved rate was 90% and the survival rate was 66.7% in a year. Those who had better response to the treatment had longer survivial.%本文采用留置导管法胸腔内注入顺铂及凝血酶治疗30例晚期肺癌患者，结果显示CR占30%，PR占60%、NR占10%，总有效率为90%。年生存率为66.7%。提示胸腔局部用药效果佳者则生存期亦延长。
展开▼
